GCP-Service International Ltd. & Co. KG

For profitWebsite ↗

Also known as: GCP ClinPlus Co., Ltd. | GCP-Service International Ltd. & Co. KG | GCP-Service International s.r.o. | GCP-Service International West GmbH | GCP services

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Nov 1, 2014

Last known activity

Mar 27, 2025

Timeline

2000s

Jan 1, 2004
GCP-Service International Ltd. & Co. KG— Founded

Drugs by trial phase (14 distinct, 13 trials)

Phase 4 (3 own, 0 via acquisition)

Phase 3 (1 own, 0 via acquisition)

anacaulase

Phase 2 (6 own, 0 via acquisition)

Phase 1 (3 own, 0 via acquisition)

Other trials (1 own, 0 via acquisition)

orelabrutinib

Indications

Studied for

Recent trials (13)

NCT07260513CollaboratorPhase 1Mar 27, 2025
NCT06243458Lead sponsorPhase 2Sep 10, 2024
NCT06279793Lead sponsorPhase 2Feb 15, 2024
NCT05583552Lead sponsorPhase 2Dec 31, 2022
NCT05534269CollaboratorPhase 2Oct 17, 2022
NCT05284175CollaboratorN/AApr 30, 2022
NCT05152355CollaboratorPhase 4Apr 22, 2019
NCT03927573CollaboratorPhase 1Apr 15, 2019
NCT04098432CollaboratorPhase 1/Phase 2Dec 3, 2018
NCT03516760CollaboratorPhase 1Apr 11, 2018
NCT03511326CollaboratorPhase 4Jun 7, 2017
NCT03044652CollaboratorPhase 4Nov 1, 2016
NCT02278718CollaboratorPhase 3Nov 1, 2014

Details

Founded: Bremen, DE Jan 1, 2004
Last known activity: Mar 27, 2025